Given that fibrosis is a common feature in both ischemic and hypertrophic cardiomyopathy, the interaction of NAP1L1 with pathways regulating cardiac remodeling, such as YAP1, may be relevant. Here, YAP1 is linked to hypertrophic cardiomyopathy.